United States Biosimilar Market Report 2023: Sector is Expected to Reach $50.68 Billion in 2027 at a CAGR of 40.17%

DUBLIN, June 30, 2023 /PRNewswire/ — The “US Biosimilar Market: Insights & Forecast with Potential Impact of COVID- 19 (2023-2027)” report has been added to ResearchAndMarkets.com’s offering. The US biosimilar market is forecasted to reach US$50.68 billion in 2027, experiencing growth at…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.